BSX vs. BTSG: Boston Scientific vs. BrightSpring Health Services Stock Comparison

Company Profile

Boston Scientific (BSX) and BrightSpring Health Services (BTSG) both fall under the Health Care Equipment & Services industry group, but BSX is classified in Health Care Equipment & Supplies while BTSG is classified in Health Care Providers & Services.

Boston Scientific (BSX) carries decades of public-market history since May 19, 1992, while BrightSpring Health Services (BTSG) listed on January 26, 2024 — long-window comparisons have far more historical data on the BSX side.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

BrightSpring Health Services (BTSG) has an aggressive beta of 1.75, indicating higher sensitivity to broad-market moves, while Boston Scientific (BSX) is defensive at 0.57 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

BrightSpring Health Services (BTSG) at 15.54% sits in the top ROE quartile, while Boston Scientific (BSX) at 14.12% is closer to the peer norm — stronger capital efficiency for BTSG.

Boston Scientific (BSX) at 16.62% retains a top-quartile share of revenue as profit, ahead of BrightSpring Health Services (BTSG) at 2.69%, which keeps about the industry-typical share.

Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of BrightSpring Health Services (BTSG) at 3.81%, which runs around its industry’s norm.

Profitability Metrics

Growth

BrightSpring Health Services (BTSG) at 28.18% sits in the top revenue growth quartile, while Boston Scientific (BSX) at 19.87% is closer to the peer norm — faster top-line expansion for BTSG.

Only one side can be read here: Boston Scientific (BSX) reports EPS growth of 55.20%, ranked against its industry; BrightSpring Health Services (BTSG) has no EPS growth figure this period.

Growth Metrics

Financial Strength

BrightSpring Health Services (BTSG) at 1.62 keeps current ratio within its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for BSX.

Boston Scientific (BSX) at 0.46 carries an industry-typical debt-to-equity mix, while BrightSpring Health Services (BTSG) at 1.09 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Neither Boston Scientific (BSX) nor BrightSpring Health Services (BTSG) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Boston Scientific (BSX) nor BrightSpring Health Services (BTSG) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

Boston Scientific (BSX) at 18.04 sits in the cheaper P/E ratio quartile, while BrightSpring Health Services (BTSG) at 47.62 is closer to its industry’s usual earnings multiple — a discount for BSX, though growth and earnings durability still matter.

BrightSpring Health Services (BTSG) at 0.88 sits in the cheaper P/S ratio quartile while Boston Scientific (BSX) at 2.94 prices around its industry’s middle — BTSG costs less per dollar of sales, though read it alongside growth and margins.

Boston Scientific (BSX) at 2.42 is valued about in line with its industry on P/B ratio, while BrightSpring Health Services (BTSG) at 6.39 carries an above-peer premium to book — BTSG is pricier on assets.

Valuation Metrics